Through the regulation of redox balance, oxidative protein folding, and regulation of hydrogen peroxide signaling, PRDX4, a 2-Cys antioxidant of peroxiredoxins, participates in the progression of breast cancer, prostate cancer, ovarian cancer, colorectal cancer, and lung cancer [41]. Here, PRDX4 is linked to prostate carcinoma.